Shopping Cart
- Remove All
- Your shopping cart is currently empty
GSK1842799 is a selective S1P1 receptor agonist for multiple sclerosis. Upon phosphorylation, GSK1842799 showed subnanomole S1P1 agonist activity with >1000× selectivity over S1P3. GSK1842799 demonstrated good oral bioavailability. On the basis of the favorable in vitro ADME and in vivo PK/PD properties as well as broad toxicology evaluations, GSK1842799 was selected as a candidate for further clinical.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | 1.729 € | 8-10 weeks | |
50 mg | 2.261 € | 8-10 weeks | |
100 mg | 2.945 € | 8-10 weeks |
Description | GSK1842799 is a selective S1P1 receptor agonist for multiple sclerosis. Upon phosphorylation, GSK1842799 showed subnanomole S1P1 agonist activity with >1000× selectivity over S1P3. GSK1842799 demonstrated good oral bioavailability. On the basis of the favorable in vitro ADME and in vivo PK/PD properties as well as broad toxicology evaluations, GSK1842799 was selected as a candidate for further clinical. |
Molecular Weight | 504.4342 |
Formula | C20H30Cl2F3N3O2S |
Cas No. | 1277165-15-7 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.